SUNIL AGARWAL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SUNIL AGARWAL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SUNIL AGARWAL. SUNIL AGARWAL is a Director in Calithera Biosciences, Inc. ($CALA) and a Chief Medical Officer in Ultragenyx Pharmaceutical Inc. ($RARE) and a Director in MyoKardia Inc ($MYOK) and a President of R & D in Juno Therapeutics, Inc. ($JUNO) and a See Remarks in Sana Biotechnology, Inc. ($SANA).
Address: C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO 94949 CA
Companies in which SUNIL AGARWAL is an Insider
Calithera Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SUNIL AGARWAL: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 11 2020
$CALA Market Capitalization: $187.67M
$CALA Previous Close: $9.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Juno Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SUNIL AGARWAL: President of R & D
Holdings: 65,028 shares
Current Value: $1,349,981
Latest Transaction: Mar 07 2018
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MyoKardia, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SUNIL AGARWAL: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 19 2020
$MYOK Market Capitalization: $375.56M
$MYOK Previous Close: $12.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sana Biotechnology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SUNIL AGARWAL: See Remarks
Holdings: 0 shares
Latest Transaction: Feb 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ultragenyx Pharmaceutical Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SUNIL AGARWAL: Chief Medical Officer
Holdings: 9,136 shares
Current Value: $666,106
Latest Transaction: Aug 23 2016
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of SUNIL AGARWAL
Sentiment: All, CALA, JUNO, MYOK, SANA, RARE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2021 | SANA | Sana Biotechnology ... | AGARWAL SUNIL | See Remarks | Option Exercise | A | 25.00 | 48,000 | 1,200,000 | 48,000 | |
| Nov 19 2020 | MYOK | MyoKardia, Inc. | AGARWAL SUNIL | Director | Option Exercise | D | 100.27 | 3,000 | 300,810 | 0 | |
| Nov 19 2020 | MYOK | MyoKardia, Inc. | AGARWAL SUNIL | Director | Option Exercise | D | 47.77 | 6,600 | 315,282 | 0 | |
| Nov 19 2020 | MYOK | MyoKardia, Inc. | AGARWAL SUNIL | Director | Option Exercise | D | 48.85 | 11,000 | 537,350 | 0 | |
| Nov 19 2020 | MYOK | MyoKardia, Inc. | AGARWAL SUNIL | Director | Option Exercise | D | 14.00 | 11,000 | 154,000 | 0 | |
| Nov 19 2020 | MYOK | MyoKardia, Inc. | AGARWAL SUNIL | Director | Option Exercise | D | 13.60 | 11,000 | 149,600 | 0 | |
| Nov 19 2020 | MYOK | MyoKardia, Inc. | AGARWAL SUNIL | Director | Option Exercise | D | 7.40 | 22,000 | 162,800 | 0 |